Startups

Cyllene Therapeutics logo

Cyllene Therapeutics

cyllene-tx.com

Cyllene Therapeutics, formerly EG 427, develops targeted DNA medicines for chronic neurological conditions, including neurogenic bladder dysfunction.

Team

Alberto EpsteinFounder and CSO
Astrid Valles-SanchezVP Translational Research
Celine BredaVP CMC
Charles JoussainCo-founder
Clara Cambon-ThiebaudVP Regulatory Affairs
Cornelia Haag-MolkentellerCMO
François GiulianoCo-founder
Marc GrassoCFO
Mikael ContrastinVP Strategy and Legal Affairs
Philippe ChambonFounder, Chairman and CEO
Pierre DenysCo-founder
Samuel SalotCOO and co-founder
Teddy JéguVP Research

Investments

$—Unknown dateSCI Ventures